Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,999 | 58,588 | 93,494 | 50,116 | N/A |
| Marketable Securities | 22,495 | 25,005 | N/A | N/A | N/A |
| Receivables | 551 | 867 | N/A | N/A | N/A |
| TOTAL | $72,505 | $85,508 | $94,881 | $52,153 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,546 | 4,850 | 4,603 | 4,773 | N/A |
| Other Non-Current Assets | 972 | 965 | 926 | 4,020 | 0 |
| TOTAL | $5,518 | $5,815 | $5,529 | $8,793 | $N/A |
| Total Assets | $78,023 | $91,323 | $100,410 | $60,946 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,377 | 2,415 | 4,039 | 1,645 | 0 |
| Accrued Expenses | 3,989 | 6,115 | 3,834 | 4,040 | N/A |
| TOTAL | $6,865 | $9,567 | $8,348 | $6,149 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 328 | 869 | 310 | 301 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2 | 0 |
| TOTAL | $1,022 | $1,154 | $1,281 | $1,403 | $N/A |
| Total Liabilities | $7,887 | $10,721 | $9,629 | $7,552 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,618 | 2,339 | 2,338 | 2,337 | N/A |
| Common Shares | 23 | 23 | 23 | 3 | N/A |
| Retained earnings | -112,771 | -101,256 | -90,291 | -76,122 | N/A |
| Other shareholders' equity | -13 | -9 | 0 | 121,807 | 0 |
| TOTAL | $70,136 | $80,602 | $90,781 | $53,394 | $N/A |
| Total Liabilities And Equity | $78,023 | $91,323 | $100,410 | $60,946 | $0 |